This method bypasses the digestive system, allowing for better absorption and faster effects
Based on consultation, peptide care may support the healing of soft tissue like muscles, ligaments, and tendons
What the new mechanism is: GLP-1 : appetite regulation, improved glucose control GIP : incretin effects that may augment metabolic benefits Glucagon receptor activity : potentially influences energy expenditure and fat metabolism (while requiring careful balancing of tolerability and metabolic effects) What results look like (so far): Phase 2 (48 weeks) published in NEJM showed substantial mean weight reductions (with higher doses showing very large effects)
In the response to food intake, it stimulates the release of insulin and inhibits the release of glucagon, which is a hormone that raises our blood sugar
Saxenda (liraglutide) is a daily injection in the same class, with around 8% average weight loss
With advancing age, GH production declines, a phenomenon paralleled by physical and functional alterations similar to those observed in AGHD
